2,900
Views
10
CrossRef citations to date
0
Altmetric
Coronaviruses

SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron

ORCID Icon, , , , , , , ORCID Icon & show all
Pages 1819-1827 | Received 19 May 2022, Accepted 30 Jun 2022, Published online: 21 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (10)